Application of DLX1, HOXC6 and PCA3 in preparing prostate cancer marker and kit of DLX1, HOXC6 and PCA3
The invention discloses application of DLX1, HOXC6 and PCA3 in preparing a prostate cancer marker and a kit of DLX1, HOXC6 and PCA3. The kit uses a multiple qRT-PCR technology to simultaneously detectDLX1/HOXC6/PCA3 mRNA in a urine sample, meanwhile, the PSA mRNA is used as a reference to establish...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses application of DLX1, HOXC6 and PCA3 in preparing a prostate cancer marker and a kit of DLX1, HOXC6 and PCA3. The kit uses a multiple qRT-PCR technology to simultaneously detectDLX1/HOXC6/PCA3 mRNA in a urine sample, meanwhile, the PSA mRNA is used as a reference to establish a Logistic regression model as an early diagnostic marker for prostate cancer. The kit is tested ina combined mode through a plurality of markers to achieve a high coincidence rate for the clinical and pathological results of prostate cancer.
本发明公开了一种DLX1,HOXC6和PCA3在制备前列腺癌标志物中的应用及其试剂盒。该试剂盒使用多重qRT-PCR技术,在一份尿液样本中同时检测DLX1/HOXC6/PCA3 mRNA,同时以PSA mRNA作参照,建立Logistic回归模型,作为前列腺癌早期诊断标志物。该试剂盒通过多个标志物联合检测,达到了对前列腺癌临床病理结果极高的符合率。 |
---|